Recordati Industria Chimica E Farmaceutica S.P.A. (RCDTF)
(Delayed Data from OTC)
$52.25 USD
0.00 (0.00%)
Updated Aug 1, 2024 02:00 PM ET
2-Buy of 5 2
B Value B Growth NA Momentum NA VGM
Price, Consensus and EPS Surprise
RCDTF 52.25 0.00(0.00%)
Will RCDTF be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for RCDTF based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for RCDTF
Jefferies Remains a Hold on Recordati Industria Chimica e Farmaceutica SPA (0KBS)
Kepler Capital Sticks to Its Hold Rating for Recordati Industria Chimica e Farmaceutica SPA (0KBS)
Recordati price target raised by EUR 1 at Barclays
Recordati Industria Chimica e Farmaceutica S.p.A. 2024 Q1 - Results - Earnings Call Presentation
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q1 2024 Earnings Call Transcript